Clik here to view.
Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating...
BOTHELL, Wash. & TOKYO & RAHWAY, N.J. Seagen Inc. (Nasdaq:SGEN), Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Merck (NYSE: MRK), known as MSD...
View ArticleClik here to view.
CANbridge Pharmaceuticals to Participate in Two Investor Conferences in...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
PDC*line Pharma Presents First Clinical Results From Phase I/II trial With...
LIÈGE, Belgium & GRENOBLE, France PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the first...
View ArticleClik here to view.
InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 in China
BEIJING InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical Products Administration)...
View ArticleClik here to view.
Rhizen Pharmaceuticals AG宣布即将在ESMO...
瑞士巴塞尔 (美国商业资讯)–总部位于瑞士的私营临床阶段生物制药公司Rhizen Pharmaceuticals AG (Rhizen)今天宣布，于2022年9月9日至13日在巴黎举行的2022年欧洲肿瘤内科学会年会(ESMO 2022)上展示正在进行的Tenalisib治疗局部晚期或转移性乳腺癌的II期试验数据，以及RP12146的剂量递增阶段的结论数据。...
View ArticleClik here to view.
METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi
CAMBRIDGE, Mass. METiS Therapeutics, a Boston-area company integrating drug discovery and delivery with AI and machine learning, today announced they have entered a license agreement with Voronoi,...
View ArticleClik here to view.
Olympus Launches VISERA ELITE III Surgical Visualization Platform
TOKYO Olympus Corporation (“Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of VISERA ELITE III, its newest surgical...
View ArticleClik here to view.
Qurient Announces Collaboration Agreement with MSD to Evaluate Selective CDK7...
SEONGNAM-SI, South Korea Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the company has entered into a clinical collaboration agreement with...
View ArticleClik here to view.
百奥赛图与泛恩生物达成基于类TCR抗体的细胞治疗药物开发合作
北京，广州 百奥赛图（北京）医药科技股份有限公司（简称“百奥赛图”，股票代码：02315.HK）宣布与广州泛恩生物科技有限公司（简称“泛恩生物”）达成合作协议，百奥赛图将利用其自主开发的类TCR抗体技术平台筛选针对特定靶点的全人抗体序列，结合泛恩生物特有的细胞治疗技术平台，共同开发针对胞内肿瘤相关抗原的创新性细胞治疗药物。...
View ArticleClik here to view.
Biocytogen Announces Collaboration with FineImmune to Develop TCR-Mimic...
BEIJING & GUANGZHOU, China Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced a strategic collaboration with Guangzhou FineImmune Biotechnology Co., LTD....
View ArticleClik here to view.
The Dragonfly Foundation Receives SBB Research Group Foundation Grant
CHICAGO The Chicago Chapter of the Dragonfly Foundation received a $5,000 grant from the SBB Research Group Foundation, which awards monthly grants to support impactful organizations during the...
View ArticleClik here to view.
知临集团提供 RPIDD 传染病液体活检分子诊断临床验证的最新資訊
纽约、伦敦和巴黎 (美国商业资讯)–知临集团（纳斯达克股票代码：APM，巴黎泛欧交易所股票代码：APM）是一家临床阶段的生物制药公司，致力于解决肿瘤学、自身免疫性疾病和传染病方面未满足的医疗需求。知临集团很高兴地宣布更多地在 Illumina iSeq 100 和 MiniSeq 测序平台1下使用RPIDD 技术分析、以及回顾性和前瞻性临床验证患者样本的最新資訊。 迄今为止，RPIDD...
View ArticleClik here to view.
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles...
BRISTOL, N.J. & SEOUL Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that it...
View ArticleClik here to view.
TCT 2022：Impellaの完全な血行再建、QOL向上、自己心機能の回復を実現
ボストン （ビジネスワイヤ） –アビオメッド（Nasdaq: ABMD）は、9月16日から19日までボストンで開催されるTranscatheter Cardiovascular Therapeutics（TCT）2022において、ハートチームがカテ室や手術室でより高リスク症例に対してより完全な血行再建と心機能回復を実現するためImpellaがどのような役割を果たすかをご紹介します。...
View ArticleClik here to view.
オリンパスがVISERA ELITE III外科可視化プラットフォームを発売
東京 （ビジネスワイヤ） — オリンパス株式会社（取締役 代表執行役 社長兼CEO：竹内康雄）は本日、複数の診療科目にわたる医療従事者の内視鏡手術ニーズに応える最新の外科可視化プラットフォーム「VISERA ELITE III」の発売を発表しました。VISERA ELITE...
View ArticleClik here to view.
奥林巴斯推出VISERA ELITE III手术可视化平台
东京 (美国商业资讯)–奥林巴斯株式会社（Olympus Corporation，简称“奥林巴斯”，取缔役、代表执行役、社长兼首席执行官：竹内康雄）今天宣布推出其最新的手术可视化平台VISERA ELITE III，以满足多科室医疗保健专业人员(HCP)对内窥镜手术的需求。VISERA ELITE...
View ArticleClik here to view.
阿联酋Burjeel Medical City成功实施首例肾脏移植手术
阿联酋阿布扎比 (美国商业资讯)–阿联酋阿布扎比的私立医院Burjeel Medical City (BMC)已开始实施肾脏移植手术，为本地和国际患者提供肾脏移植选择。BMC是Burjeel Holdings旗下一个卓越的四级医疗中心，为来自哈萨克斯坦的一名患者成功实施了首例肾脏移植手术。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
DentalMonitoring推出DM Insights
巴黎 (美国商业资讯)–DM智能平台迎来新成员DM Insights。DM智能平台是DentalMonitoring的全套解决方案，旨在提高护理质量和改善患者体验，同时积累实践。DM Insights不仅仅是一个数据分析工具，也让医生、诊疗室和合作伙伴能够获取与临床和运营效率有关的连续、实时反馈和信息。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from...
DANVERS, Mass. Abiomed (Nasdaq: ABMD) announces two approvals from the U.S. Food and Drug Administration (FDA) related to clinical research of Impella heart pumps in acute myocardial infarction...
View ArticleClik here to view.
UAEのバージール・メディカル・シティが初の腎臓移植を成功裏に実施
アラブ首長国連邦アブダビ （ビジネスワイヤ） — アラブ首長国連邦アブダビの民間病院において国内外の患者に腎臓移植の選択肢を提供するバージール・メディカル・シティ（BMC）は、腎臓移植の実施を開始しました。バージール・ホールディングス傘下の4次卓越医療センターであるBMCでは、カザフスタン出身の患者に初めて腎臓移植が成功裏に行われました。...
View Article